Media

The Science behind Ifenprodil and COVID -19
Sep 08, 2020
Uncategorized

The Science behind Ifenprodil and COVID -19

  Dr. Mark Williams, Chief Science Officer of Algernon …

Algernon Pharmaceuticals provides update on Phase 2B/3 study as they enroll 50th patient
Sep 02, 2020
Uncategorized

Algernon Pharmaceuticals provides update on Phase 2B/3 study as they enroll 50th patient

Algernon Pharmaceuticals provides update on Phase 2B/3 study as they …

Algernon Pharmaceuticals has big upside, says Mackie Research
Aug 24, 2020
Uncategorized

Algernon Pharmaceuticals has big upside, says Mackie Research

Algernon Pharmaceuticals has big upside, says Mackie Research   …
Algernon Pharmaceuticals is a clinical stage pharmaceutical development company focused on the areas of non–alcoholic steatohepatitis (NASH), chronic kidney disease (CKD), inflammatory bowel disease (IBD) and idiopathic Pulmonary fibrosis. (IPF)
Sign up for our News Releases and Updates

Head Office

Suite 915 – 700 West Pender Street
Vancouver, BC, Canada • V6C 1G8

Follow Us On

Hit enter to search or ESC to close

Share via
Facebook
Twitter
LinkedIn
Mix
Pinterest
Tumblr
Skype
Buffer
Pocket
VKontakte
Xing
Reddit
Flipboard
MySpace
Delicious
Amazon
Digg
Evernote
Blogger
LiveJournal
Baidu
NewsVine
Yummly
Yahoo
WhatsApp
Viber
SMS
Telegram
Facebook Messenger
Like
Email
Print
Copy Link
Powered by Social Snap
Copy link
CopyCopied
Powered by Social Snap